Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
MEDP Analyst Ratings
Hold
1 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MEDP Stock 12 Month Forecast
Average Price Target
$315.86
▼(-3.12%Downside)
| Highest Price Target$355.00 | Average Price Target$315.86 | Lowest Price Target$285.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$336
Buy
3.06%
Upside
Reiterated
06/19/25
Medpace Holdings is well-positioned in the Medical - Diagnostics & Research industry, with strong financial performance being the most significant contributor to its score. However, technical indicators and valuation present a moderate outlook, while mixed earnings call sentiment points to challenges that could impact future growth.
Barclays
$300
Hold
-7.98%
Downside
Initiated
06/24/25
Truist Financial
$300
Hold
-7.98%
Downside
Reiterated
06/06/25
William Blair
―
Hold
―
Reiterated
05/19/25
Robert W. Baird
$340→$313
Hold
-4.00%
Downside
Reiterated
04/23/25
TD Cowen
$328
Hold
0.60%
Upside
Reiterated
04/22/25
Jefferies
$300→$285
Hold
-12.58%
Downside
Reiterated
04/21/25
Leerink Partners
$330
Hold
1.22%
Upside
Reiterated
04/21/25
Mizuho Securities
$400→$355
Buy
8.89%
Upside
Reiterated
04/09/25
UBS
$480→$350
Hold
7.35%
Upside
Downgraded
09/26/24
Guggenheim
$464→$432
Buy
32.50%
Upside
Reiterated
07/24/24
Deutsche Bank
$336
Hold
3.06%
Upside
Assigned
07/24/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$336
Buy
3.06%
Upside
Reiterated
06/19/25
Medpace Holdings is well-positioned in the Medical - Diagnostics & Research industry, with strong financial performance being the most significant contributor to its score. However, technical indicators and valuation present a moderate outlook, while mixed earnings call sentiment points to challenges that could impact future growth.
Barclays
$300
Hold
-7.98%
Downside
Initiated
06/24/25
Truist Financial
$300
Hold
-7.98%
Downside
Reiterated
06/06/25
William Blair
―
Hold
―
Reiterated
05/19/25
Robert W. Baird
$340→$313
Hold
-4.00%
Downside
Reiterated
04/23/25
TD Cowen
$328
Hold
0.60%
Upside
Reiterated
04/22/25
Jefferies
$300→$285
Hold
-12.58%
Downside
Reiterated
04/21/25
Leerink Partners
$330
Hold
1.22%
Upside
Reiterated
04/21/25
Mizuho Securities
$400→$355
Buy
8.89%
Upside
Reiterated
04/09/25
UBS
$480→$350
Hold
7.35%
Upside
Downgraded
09/26/24
Guggenheim
$464→$432
Buy
32.50%
Upside
Reiterated
07/24/24
Deutsche Bank
$336
Hold
3.06%
Upside
Assigned
07/24/24
Best Analysts Covering Medpace Holdings
1 Month
xxx
Success Rate
1/5 ratings generated profit
Average Return
-2.82%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -2.82% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
Average Return
-3.92%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -3.92% per trade.
1 Year
2 Years
xxx
Success Rate
1/5 ratings generated profit
Average Return
-7.06%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -7.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MEDP Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
3
4
4
2
1
Hold
5
6
14
12
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
10
18
14
13
Each month's total comprises the sum of three months' worth of ratings.
MEDP Financial Forecast
MEDP Stock Forecast FAQ
What is MEDP’s average 12-month price target, according to analysts?
Based on analyst ratings, Medpace Holdings’s 12-month average price target is 315.86.
What is MEDP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MEDP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MEDP a Buy, Sell or Hold?
Medpace Holdings has a consensus rating of Hold which is based on 1 buy ratings, 7 hold ratings and 0 sell ratings.
What is Medpace Holdings’s price target?
The average price target for Medpace Holdings is 315.86. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $355.00 ,the lowest forecast is $285.00. The average price target represents -3.12% Decrease from the current price of $326.03.
The highest analyst price target is $355.00 ,the lowest forecast is $285.00. The average price target represents -3.12% Decrease from the current price of $326.03.
What do analysts say about Medpace Holdings?
Medpace Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of MEDP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.